Journal Article

Evolution of statin therapy: an ongoing story

O Faergeman

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 6, issue suppl_A, pages A3-A7
Published in print March 2004 | ISSN: 1520-765X
Published online March 2004 | e-ISSN: 1554-2815 | DOI:
Evolution of statin therapy: an ongoing story

Show Summary Details


Major clinical end-point trials of cholesterol lowering with statins have shown consistent benefits in prevention of cardiovascular disease. Lessons from these trials include the findings that cardiovascular risk reduction is: (1) dependent on baseline cardiovascular risk; (2) dependent on magnitude of low-density lipoprotein cholesterol (LDL-C) reduction achieved with treatment; and (3) independent of initial LDL-C level. Ongoing studies will help to identify new markers of higher risk/higher treatment benefit and to define the merits of more aggressive LDL-C lowering.

Keywords: Statins; Cholesterol lowering; Cardiovascular disease risk; Low-density lipoprotein; Coronary heart disease

Journal Article.  2005 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.